Prostaglandins and cyclic nucleotides in the Chédiak-Higashi syndrome and experimental systemic lupus erythematosus.
D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage; D002609:Chediak-Higashi Syndrome / Q000276:immunology / Q000378:metabolism*; D003208:Concanavalin A / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D006801:Humans; D007111:Immunity, Cellular; D007962:Leukocytes / Q000187:drug effects; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008814:Mice, Inbred NZB; D011453:Prostaglandins / Q000378:metabolism*
D011453:Prostaglandins; D003208:Concanavalin A; D006152:Cyclic GMP; D001205:Ascorbic Acid